Clinical Trial Update: Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting completion and posted results for chemotherapy with a monoclonal antibody and radioimmunotherapy in high-risk B-cell non-Hodgkin …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Snippet

Sponsor: Duke University | Conditions: Lymphoma, B-Cell | Phase 2 | Status: COMPLETED | Results posted: 2013-04-15